DGB-01 Effects on Endurance Exercise
|Age Range:||18 - 60|
|Start Date:||February 2012|
|Contact:||William Black, MD|
The purpose of this research is to evaluate the effects of DGB-01 on performance of a 40‐km
time trial in trained male cyclists. The investigators believe that DGB-01 will improve
performance on the time trial as measured by a reduction in the amount of time required to
complete the distance, using a computerized cycle ergometer.
- Healthy males who are trained cyclists with a maximal oxygen uptake relative to body
weight equal to or greater than 45 ml O2/kg/min.
- Subjects must be in the competitive phase of their annual training cycle.
- Between ages of 18-60
- Availability- commitment of the subject/expected participation in the study for 97
- Specific allergy to milk proteins (this is different from lactose intolerance)
- Use of immunosuppressive medication in the case of organ transplants
- Planned surgeries.
- Kidney disorders
- Use of antihypertensive medications
- Cardiovascular disease
- Abnormal BUN, creatinine, hemoglobin, or hematocrit
- Body weight greater than 285 pounds
- A protein-restricted diet
- Subjects currently using dry whey protein supplements, N-acetylcysteine, or
alpha-lipoic acid supplements. The wash-out period is 1 month for any of these
- All medications that can interfere with muscle mass such as corticosteroids (e.g.
prednisone), testosterone replacement or anabolic drugs such as Megace
We found this trial at
Lexington, Kentucky 40536
Click here to add this to my saved trials